Phase I BKM120/Abraxane in Solid Tumors, Expansion Phase Recurrent Endometrial or Ovarian Cancer

NCT02117817 · clinicaltrials.gov ↗

PHASE1

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Research cancelled

Conditions

Ovarian Cancer
Endometrial Cancer
Recurrent Ovarian Cancer
Recurrent Endometrial Cancer

Interventions

DRUG: BKM120
DRUG: Nabpaclitaxel

Sponsor

Rutgers, The State University of New Jersey

Collaborators

[object Object]
[object Object]